National Center for Complementary and Alternative Medicine (NCCAM)

NIH…Turning Discovery Into Health®

Follow NCCAM: Subscribe to our email update Subscribe to the NCCAM RSS feed Follow NCCAM on TwitterRead our disclaimer about external links Follow NCCAM on FacebookRead our disclaimer about external links

Menu

This page is an historical document and contains content that may be out of date.

Minutes of the Ninth Meeting - November 21, 2001

National Advisory Council for Complementary and Alternative Medicine (NACCAM)

On this page:

  1. Call to Order
  2. Opening Remarks
  3. Public Comment
  4. Closed Session
  5. Adjournment

NACCAM Council Members Present

  • Dr. Michael Cantwell, Complementary Medicine Research Institute, California Pacific Medical Center, San Francisco, CA
  • *Dr. Zang-Hee Cho, Professor, Radiological Sciences, Psychiatry and Human Behavior, and Ophthalmology, University of California at Irvine, CA
  • Dr. Haile T. Debas, Dean, School of Medicine, University of California, San Francisco, CA
  • *Dr. Murray Goldstein, UCP Research and Educational Foundation, Washington, DC
  • Dr. Richard H. Grimm, Director, Department of Internal Medicine, Berman Center for Outcomes and Clinical Research, Minneapolis, MN
  • *Dr. Michael Irwin, San Diego Veterans Affairs Medical Center, San Diego, CA
  • Dr. Janet Kahn, Peace Village Projects, Burlington, VT
  • Dr. Konrad Kail, Naturopathic Physician, Naturopathic Family Care, Phoenix, AZ
  • Dr. Ted Kaptchuk, Asst. Prof. of Medicine, Harvard Medical School, Boston, MA
  • Dr. Dana Lawrence, Director, Department of Publications and Editorial Review, National College of Chiropractic, Lombard, IL
  • Ms. Diana C. Manley, Massage Therapist, New Bern, NC
  • Dr. William Meeker, Director of Research, Palmer Chiropractic University Foundation, Davenport, IA
  • Dr. Karen Olness, Professor, Department of Pediatrics, School of Medicine, Case Western Reserve University, Tainbow Babies and Children’s Hospital, Cleveland, OH
  • Dr. Herbert Pardes, Vice President for Health Sciences and Dean of the Faculty of Medicine, New York Presbyterian Hospital, New York, NY
  • Dr. Everett R. Rhoades, University of Oklahoma College of Public Health, Oklahoma City, OK
  • Dr. Barbara Timmermann, Professor, Department of Pharmacology/Toxicology, University of Arizona, Tucson, Arizona
  • Col. James Williams (Ret), Pennsylvania Prostate Cancer Coalition, Camp Hill, PA

*Ad Hoc members

Top

NIH Staff Present

  • Ms. Victoria Carper, NCCAM
  • Ms. Linda Engel, NCCAM
  • Ms. Marguerite Evans, NCCAM
  • Ms. Carol Fitzpatrick-Mulligan, NCCAM
  • Dr. Martin Goldrosen, NCCAM
  • Ms. Carolyn Hodgkins, NCCAM
  • Ms. Camille Hoover, NCCAM
  • Dr. Morgan Jackson, NCCAM
  • Dr. Jane Kinsel, NCCAM
  • Dr. Richard Nahin, NCCAM
  • Dr. Nancy Pearson, NCCAM
  • Dr. Mary Ann Richardson, NCCAM
  • Dr. Stephen Straus, Director, NCCAM
  • Dr. Neal West, NCCAM
  • Ms. Kerry Whichard, NCCAM
  • Dr. Shan Wong, NCCAM

Top

I. Call to Order, Introductory Remarks, Future Meeting Dates, and Meeting Procedures

The National Advisory Council for Complementary and Alternative Medicine (NACCAM) convened at 12:00 noon on November 21, 2001, by conference call. Dr. Jane Kinsel, Executive Secretary, called the meeting to order and reviewed the agenda: a short open session with an opportunity for public comment, followed by a closed session. Dr. Kinsel reviewed the general rules under which Council must operate. The general public may attend the open session; as required by law, there is an opportunity for public comment. The closed session of the meeting is closed to the public in accordance with the provisions set forth in Section 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2). Attendance at the closed session is limited to Council members and appropriate NIH and DHHS staff. The next Council meetings are scheduled for January 28, 2002, and May 28, 2002.

Top

II. Opening Remarks

Dr. Stephen Straus reported on a hearing, Comprehensive Medical Care for Bioterrorism Exposure—Are We Making Evidence-Based Decisions, held by Rep. Dan Burton [R-IN], Chair of the House Committee on Government Reform and Oversight on November 14. It was an important opportunity to state that CAM has potential to be used for a variety of indications. Many people are looking to CAM treatments to help them treat or prevent diseases, such as those that could be caused by weapons of bioterrorism. While many CAM practices do have a place in treating other conditions, no CAM practice has been shown to protect against these diseases. NCCAM welcomes proposals from researchers who study CAM approaches for major public health problems, including those of bioterrorism. Dr. Straus’ testimony and other information about bioterrorism can be found on the NCCAM website.

Dr. Straus provided an update of FY 2001 Center activities and told the Council members that a listing of the awards made in FY 2001 could be found on the NCCAM website. A fuller discussion of the budget will be presented at the January 28, 2002, Council meeting.

Dr. Straus informed Council that NCCAM staff, led by Dr. Joana Rosario, NCCAM’s Director of the Office of International Health Research, recently held a research symposium in Singapore on Traditional Chinese Medicine and a workshop on clinical research methodology and grantsmanship as part of an effort to include international institutions in NCCAM’s research efforts. Another purpose of the meeting was to share knowledge of NIH expertise and research. Dr. Straus also mentioned that the annual meeting of the directors of the centers funded by NCCAM will be held March 18-19, 2002, in Portland, Oregon. In conjunction with this center directors meeting, NCCAM will convene the third NCCAM town meeting for the general public.

Finally, Dr. Straus reported that searches are actively underway to fill the vacancies for the position of Director at the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), and the National Institute of Biomedical Imaging and Bioengineering (NIBIB).

Top

III. Public Comment

A public comment session was held, as required by law. There was no comment by the public.

IV. Closed Session

The remainder of the meeting was closed to the public in accordance with the provisions set forth in Section 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

The closed session began at 12:45 p.m. A total of 129 applications were assigned to and reviewed by NCCAM. Applications that were noncompetitive, unscored, or not recommended for further consideration by the initial review groups were not considered by Council. Council reviewed and concurred with 79 applications requesting $42,925,653 in total costs.

Top

V. Adjournment

There being no further business, the meeting was adjourned at 3:30 p.m.

We hereby certify that, to the best of our knowledge, the foregoing minutes are accurate and complete.

Jane F. Kinsel, Ph.D.
Executive Secretary
National Advisory Council for Complementary and Alternative Medicine
Stephen E. Straus, M.D.
Chair
National Advisory Council for Complementary and Alternative Medicine




Top